Frank Takkinen
Stock Analyst at Lake Street
(0.90)
# 3,897
Out of 4,989 analysts
62
Total ratings
26.32%
Success rate
-14.84%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELUT Elutia | Maintains: Buy | $8 → $6 | $1.06 | +466.04% | 4 | Sep 10, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $1.47 | +36.05% | 2 | Aug 14, 2025 | |
| SGHT Sight Sciences | Upgrades: Buy | $3 → $5 | $3.52 | +42.05% | 5 | Aug 8, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $77.04 | +94.70% | 2 | Aug 5, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $12 → $8 | $1.82 | +339.56% | 2 | Jul 31, 2025 | |
| ANGO AngioDynamics | Initiates: Buy | $24 | $10.79 | +122.43% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $22.87 | +31.18% | 1 | Jun 12, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $1.41 | +254.61% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $7.45 | +87.92% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $12.46 | +20.39% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $17.30 | +73.41% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $17.85 | +45.66% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $12.20 | +145.90% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $4.03 | +24.07% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.78 | +318.41% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.40 | +108.33% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.54 | +419.48% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $41.10 | -27.01% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.85 | +605.80% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.93 | +36.52% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $10.39 | +15.50% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.09 | +330.68% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.42 | +561.16% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.43 | +2,031.64% | 2 | Jan 18, 2023 |
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.06
Upside: +466.04%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.47
Upside: +36.05%
Sight Sciences
Aug 8, 2025
Upgrades: Buy
Price Target: $3 → $5
Current: $3.52
Upside: +42.05%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $77.04
Upside: +94.70%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $1.82
Upside: +339.56%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.79
Upside: +122.43%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $22.87
Upside: +31.18%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.41
Upside: +254.61%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.45
Upside: +87.92%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.46
Upside: +20.39%
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $17.30
Upside: +73.41%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $17.85
Upside: +45.66%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $12.20
Upside: +145.90%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $4.03
Upside: +24.07%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.78
Upside: +318.41%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.40
Upside: +108.33%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.54
Upside: +419.48%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $41.10
Upside: -27.01%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.85
Upside: +605.80%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.93
Upside: +36.52%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $10.39
Upside: +15.50%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $2.09
Upside: +330.68%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.42
Upside: +561.16%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.43
Upside: +2,031.64%